| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647643 | Multiple Sclerosis and Related Disorders | 2018 | 9 Pages |
Abstract
This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Navid Manouchehri, Omid Mirmosayyeb, Shervin Badihian, Vahid Shaygannejad,